Patent · US Active

Anti-α5β1 antibodies and uses thereof

US8962275B2 · kind B2 · utility

9Cited by
17References
9Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 22, 2011
Grant dateFeb 24, 2015
Priority date
Expiry dateNov 7, 2032

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides new anti-α5β1 antibodies, compositions and kits comprising the antibodies, and methods of making and using the antibodies.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.